By Chinese Academy of Sciences – SciTechDaily –
A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, potentially reshaping how these treatments are produced.
Chinese scientists have reported a new technique that makes it easier to genetically modify natural killer (NK) cells for use in cancer immunotherapy.
In the immune system, NK cells provide rapid, early protection against viruses and cancer, along with other important functions. That combination has made them a strong candidate for immunotherapy. One example is chimeric antigen receptor (CAR)-NK therapy, where researchers equip an NK cell with a lab-built receptor (a CAR) so it can spot a specific antigen on a cancer cell and then attack.
